Recently, Machelke et al. found that epidermal growth factor receptor (EGFR) inhibition in A549 lung cancer cells leads to reduced IL-1β-induced tissue factor (TF) expression, which normally promotes tumor progression and angiogenesis [102]. The gene discussed is EGFR; the disease is lung carcinoma.